These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia. Faghihi G; Iraji F; Siadat AH; Saber M; Jelvan M; Hoseyni MS J Cosmet Dermatol; 2022 Oct; 21(10):4447-4453. PubMed ID: 35152531 [TBL] [Abstract][Full Text] [Related]
9. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review. Sung CT; Juhasz ML; Choi FD; Mesinkovska NA J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366 [TBL] [Abstract][Full Text] [Related]
10. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies. Gassmueller J; Hoffmann R; Webster A Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS-A prospective study. Kapoor R; Shome D; Doshi K; Patel G; Vadera S J Cosmet Dermatol; 2020 Oct; 19(10):2637-2646. PubMed ID: 33460214 [TBL] [Abstract][Full Text] [Related]
12. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia. Roberts J; Desai N; McCoy J; Goren A Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia. Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377 [No Abstract] [Full Text] [Related]
14. Effects of microneedling with 5% minoxidil topical solution combination therapy in treatment of androgenetic alopecia. Jia L; Xiong J; Guo R; Li Y; Jiang H J Cosmet Dermatol; 2022 Nov; 21(11):5665-5671. PubMed ID: 35861653 [TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747 [TBL] [Abstract][Full Text] [Related]
16. Low-Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% to Bring a Sustainable Hair Regrowth Activity. Mahe YF; Cheniti A; Tacheau C; Antonelli R; Planard-Luong L; de Bernard S; Buffat L; Barbarat P; Kanoun-Copy L Lasers Surg Med; 2021 Nov; 53(9):1208-1219. PubMed ID: 33973663 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of QR678 Neo Shome D; Kapoor R; Surana M; Vadera S; Shah R J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139 [TBL] [Abstract][Full Text] [Related]
18. Topical minoxidil for hair regrowth. Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289 [TBL] [Abstract][Full Text] [Related]
19. SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth. Dhurat R; Daruwalla S; Pai S; Kovacevic M; McCoy J; Shapiro J; Sinclair R; Vano-Galvan S; Goren A J Cosmet Dermatol; 2022 Jan; 21(1):343-346. PubMed ID: 34133836 [TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]